This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Laboratory Animal Model Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Animal Type (Rats, Mice, Guinea Pigs, Rabbits, and Others); Application(Drug dDiscovery & Development, Basic Research, and Others); End-User (Pharma & Biotech Companies, Academic Research Institutes, and Others); and Geography
The science and activities relating to the identification, assessment, understanding, and prevention of adverse effects or any other drug-related problem is referred to as pharmacovigilance (PV). In the pharmaceutical and biotechnology industries, pharmacovigilance is crucial in the development of drugs and their dosage forms. Pharmacovigilance is gathering information from healthcare practitioners and patients in order to learn about pharmaceutical risks, benefits and contraindications associated with the medication.
MARKET SCOPE
The "Global Pharmacovigilance Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the pharmacovigilance market with detailed market segmentation by clinical trial phase, service provider, type of method and end user. The report provides key statistics on the market status of the leading pharmacovigilance market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
Based on clinical trial phase the market is segmented as, pre-clinical, phase-I, Phase-II, phase-III, phase-IV.
Based on service provider the market is segmented as, in-house, contract outsourcing.
Based on type of method the market is segmented as, spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort, event monitoring, EHR mining.
Based on end user the market is segmented as, hospitals, research organizations, pharmaceutical and biotech companies.
MARKET DYNAMICS Drivers:
Fast growth in pharmaceutical & biotechnology companies.
Increasing number of new drug launches and growth in clinical and preclinical trials.
Growing government support and funding for clinical trials and post market studies for assesing safety of drugs.
Rising prevalences of ADR across the globe is also expected to spur market growth during the forecast period.
Restraints:
Issues such as dearth of skilled professionals, issue of data security and need for continuous monitoring are expected to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Pharmacovigilance market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Pharmacovigilance market in these regions.
IMPACT OF COVID-19 ON PHARMACOVIGILANCE MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. At this time, health agencies across the world are reviewing the pandemic's impact and offering fresh guidelines on how sponsors should manage clinical trials and MAHs should manage pharmacovigilance systems. Sponsors should be more watchful and proactive in evaluating the consequences of the pandemic and changes in authority expectations in order to minimize the impact on safety reporting and protect patient safety in this fast changing environment. To avoid clinical disturbances, it is now more necessary than ever to request new instructions and quickly adopt regulatory changes. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the Pharmacovigilance market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Pharmacovigilance market are anticipated to lucrative growth opportunities in the future with the rising demand for Pharmacovigilance in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Pharmacovigilance market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
Accenture
Cognizant
IQVIA Inc
Sciformix
Cognizant
Tata Consultancy Services Limited
Capgemini
IBM
Parexel International Corporation
Wipro Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
"1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Laboratory Animal Model - By Animal Type
1.3.2 Laboratory Animal Model - By Application
1.3.3 Laboratory Animal Model - By End-User
1.3.4 Laboratory Animal Model - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LABORATORY ANIMAL MODEL LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LABORATORY ANIMAL MODEL - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LABORATORY ANIMAL MODEL - GLOBAL MARKET ANALYSIS
6.1. LABORATORY ANIMAL MODEL - GLOBAL MARKET OVERVIEW
6.2. LABORATORY ANIMAL MODEL - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. LABORATORY ANIMAL MODEL - REVENUE AND FORECASTS TO 2028 - ANIMAL TYPE
7.1. OVERVIEW
7.2. ANIMAL TYPE MARKET FORECASTS AND ANALYSIS
7.3. RATS
7.3.1. Overview
7.3.2. Rats Market Forecast and Analysis
7.4. MICE
7.4.1. Overview
7.4.2. Mice Market Forecast and Analysis
7.5. GUINEA PIGS
7.5.1. Overview
7.5.2. Guinea Pigs Market Forecast and Analysis
7.6. RABBITS
7.6.1. Overview
7.6.2. Rabbits Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. LABORATORY ANIMAL MODEL - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DRUG DISCOVERY AND DEVELOPMENT
8.3.1. Overview
8.3.2. Drug Discovery and Development Market Forecast and Analysis
8.4. BASIC RESEARCH
8.4.1. Overview
8.4.2. Basic Research Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. LABORATORY ANIMAL MODEL - REVENUE AND FORECASTS TO 2028 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMA AND BIOTECH COMPANIES
9.3.1. Overview
9.3.2. Pharma and Biotech Companies Market Forecast and Analysis
9.4. ACADEMIC RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Academic Research Institutes Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. LABORATORY ANIMAL MODEL REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Laboratory Animal Model Overview
10.1.2 North America Laboratory Animal Model Forecasts and Analysis
10.1.3 North America Laboratory Animal Model Forecasts and Analysis - By Animal Type
10.1.4 North America Laboratory Animal Model Forecasts and Analysis - By Application
10.1.5 North America Laboratory Animal Model Forecasts and Analysis - By End-User
10.1.6 North America Laboratory Animal Model Forecasts and Analysis - By Countries
10.1.6.1 United States Laboratory Animal Model
10.1.6.1.1 United States Laboratory Animal Model by Animal Type
10.1.6.1.2 United States Laboratory Animal Model by Application
10.1.6.1.3 United States Laboratory Animal Model by End-User
10.1.6.2 Canada Laboratory Animal Model
10.1.6.2.1 Canada Laboratory Animal Model by Animal Type
10.1.6.2.2 Canada Laboratory Animal Model by Application
10.1.6.2.3 Canada Laboratory Animal Model by End-User
10.1.6.3 Mexico Laboratory Animal Model
10.1.6.3.1 Mexico Laboratory Animal Model by Animal Type
10.1.6.3.2 Mexico Laboratory Animal Model by Application
10.1.6.3.3 Mexico Laboratory Animal Model by End-User
10.2. EUROPE
10.2.1 Europe Laboratory Animal Model Overview
10.2.2 Europe Laboratory Animal Model Forecasts and Analysis
10.2.3 Europe Laboratory Animal Model Forecasts and Analysis - By Animal Type
10.2.4 Europe Laboratory Animal Model Forecasts and Analysis - By Application
10.2.5 Europe Laboratory Animal Model Forecasts and Analysis - By End-User
10.2.6 Europe Laboratory Animal Model Forecasts and Analysis - By Countries
10.2.6.1 Germany Laboratory Animal Model
10.2.6.1.1 Germany Laboratory Animal Model by Animal Type
10.2.6.1.2 Germany Laboratory Animal Model by Application
10.2.6.1.3 Germany Laboratory Animal Model by End-User
10.2.6.2 France Laboratory Animal Model
10.2.6.2.1 France Laboratory Animal Model by Animal Type
10.2.6.2.2 France Laboratory Animal Model by Application
10.2.6.2.3 France Laboratory Animal Model by End-User
10.2.6.3 Italy Laboratory Animal Model
10.2.6.3.1 Italy Laboratory Animal Model by Animal Type
10.2.6.3.2 Italy Laboratory Animal Model by Application
10.2.6.3.3 Italy Laboratory Animal Model by End-User
10.2.6.4 Spain Laboratory Animal Model
10.2.6.4.1 Spain Laboratory Animal Model by Animal Type
10.2.6.4.2 Spain Laboratory Animal Model by Application
10.2.6.4.3 Spain Laboratory Animal Model by End-User
10.2.6.5 United Kingdom Laboratory Animal Model
10.2.6.5.1 United Kingdom Laboratory Animal Model by Animal Type
10.2.6.5.2 United Kingdom Laboratory Animal Model by Application
10.2.6.5.3 United Kingdom Laboratory Animal Model by End-User
10.2.6.6 Rest of Europe Laboratory Animal Model
10.2.6.6.1 Rest of Europe Laboratory Animal Model by Animal Type
10.2.6.6.2 Rest of Europe Laboratory Animal Model by Application
10.2.6.6.3 Rest of Europe Laboratory Animal Model by End-User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Laboratory Animal Model Overview
10.3.2 Asia-Pacific Laboratory Animal Model Forecasts and Analysis
10.3.3 Asia-Pacific Laboratory Animal Model Forecasts and Analysis - By Animal Type
10.3.4 Asia-Pacific Laboratory Animal Model Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Laboratory Animal Model Forecasts and Analysis - By End-User
10.3.6 Asia-Pacific Laboratory Animal Model Forecasts and Analysis - By Countries
10.3.6.1 Australia Laboratory Animal Model
10.3.6.1.1 Australia Laboratory Animal Model by Animal Type
10.3.6.1.2 Australia Laboratory Animal Model by Application
10.3.6.1.3 Australia Laboratory Animal Model by End-User
10.3.6.2 China Laboratory Animal Model
10.3.6.2.1 China Laboratory Animal Model by Animal Type
10.3.6.2.2 China Laboratory Animal Model by Application
10.3.6.2.3 China Laboratory Animal Model by End-User
10.3.6.3 India Laboratory Animal Model
10.3.6.3.1 India Laboratory Animal Model by Animal Type
10.3.6.3.2 India Laboratory Animal Model by Application
10.3.6.3.3 India Laboratory Animal Model by End-User
10.3.6.4 Japan Laboratory Animal Model
10.3.6.4.1 Japan Laboratory Animal Model by Animal Type
10.3.6.4.2 Japan Laboratory Animal Model by Application
10.3.6.4.3 Japan Laboratory Animal Model by End-User
10.3.6.5 South Korea Laboratory Animal Model
10.3.6.5.1 South Korea Laboratory Animal Model by Animal Type
10.3.6.5.2 South Korea Laboratory Animal Model by Application
10.3.6.5.3 South Korea Laboratory Animal Model by End-User
10.3.6.6 Rest of SouthEast Asia Laboratory Animal Model
10.3.6.6.1 Rest of SouthEast Asia Laboratory Animal Model by Animal Type
10.3.6.6.2 Rest of SouthEast Asia Laboratory Animal Model by Application
10.3.6.6.3 Rest of SouthEast Asia Laboratory Animal Model by End-User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Laboratory Animal Model Overview
10.4.2 Middle East and Africa Laboratory Animal Model Forecasts and Analysis
10.4.3 Middle East and Africa Laboratory Animal Model Forecasts and Analysis - By Animal Type
10.4.4 Middle East and Africa Laboratory Animal Model Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Laboratory Animal Model Forecasts and Analysis - By End-User
10.4.6 Middle East and Africa Laboratory Animal Model Forecasts and Analysis - By Countries
10.4.6.1 South Africa Laboratory Animal Model
10.4.6.1.1 South Africa Laboratory Animal Model by Animal Type
10.4.6.1.2 South Africa Laboratory Animal Model by Application
10.4.6.1.3 South Africa Laboratory Animal Model by End-User
10.4.6.2 Saudi Arabia Laboratory Animal Model
10.4.6.2.1 Saudi Arabia Laboratory Animal Model by Animal Type
10.4.6.2.2 Saudi Arabia Laboratory Animal Model by Application
10.4.6.2.3 Saudi Arabia Laboratory Animal Model by End-User
10.4.6.3 U.A.E Laboratory Animal Model
10.4.6.3.1 U.A.E Laboratory Animal Model by Animal Type
10.4.6.3.2 U.A.E Laboratory Animal Model by Application
10.4.6.3.3 U.A.E Laboratory Animal Model by End-User
10.4.6.4 Rest of Middle East and Africa Laboratory Animal Model
10.4.6.4.1 Rest of Middle East and Africa Laboratory Animal Model by Animal Type
10.4.6.4.2 Rest of Middle East and Africa Laboratory Animal Model by Application
10.4.6.4.3 Rest of Middle East and Africa Laboratory Animal Model by End-User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Laboratory Animal Model Overview
10.5.2 South and Central America Laboratory Animal Model Forecasts and Analysis
10.5.3 South and Central America Laboratory Animal Model Forecasts and Analysis - By Animal Type
10.5.4 South and Central America Laboratory Animal Model Forecasts and Analysis - By Application
10.5.5 South and Central America Laboratory Animal Model Forecasts and Analysis - By End-User
10.5.6 South and Central America Laboratory Animal Model Forecasts and Analysis - By Countries
10.5.6.1 Brazil Laboratory Animal Model
10.5.6.1.1 Brazil Laboratory Animal Model by Animal Type
10.5.6.1.2 Brazil Laboratory Animal Model by Application
10.5.6.1.3 Brazil Laboratory Animal Model by End-User
10.5.6.2 Argentina Laboratory Animal Model
10.5.6.2.1 Argentina Laboratory Animal Model by Animal Type
10.5.6.2.2 Argentina Laboratory Animal Model by Application
10.5.6.2.3 Argentina Laboratory Animal Model by End-User
10.5.6.3 Rest of South and Central America Laboratory Animal Model
10.5.6.3.1 Rest of South and Central America Laboratory Animal Model by Animal Type
10.5.6.3.2 Rest of South and Central America Laboratory Animal Model by Application
10.5.6.3.3 Rest of South and Central America Laboratory Animal Model by End-User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LABORATORY ANIMAL MODEL
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. LABORATORY ANIMAL MODEL, KEY COMPANY PROFILES
The List of Companies
- Charles River Laboratories International, Inc.
- Envigo
- Eurofins Scientific
- genOway
- Hera Biolabs
- JSR Life Sciences, LLC (Crown Bioscience International)
- Ozgene Pty Ltd.
- PerkinElmer (Horizon Discovery Ltd.)
- Taconic Biosciences, Inc.
- THE JACKSON LABORATORY
